Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury
- PMID: 22695436
- DOI: 10.1097/TA.0b013e318246887e
Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury
Abstract
Background: Diffuse axonal injury (DAI) is a common type of traumatic brain injury, mostly associated with mild changes on computed tomography (CT) scan. Serum biomarkers might be used in the diagnosis and prognosis of this injury type. Our purpose was to determine temporal profile and predictive values of serum concentrations of protein S100BB and neuron-specific enolase (NSE) after DAI.
Methods: Twenty-eight isolated severe DAI patients (Glasgow Coma Scale score ≤ 8) with normal CT were enrolled in the study. Serum levels of S100BB and NSE were determined at 6 hours, 24 hours, 48 hours, and 72 hours after injury, using enzyme-linked immunosorbent assay. Clinical outcome variables of DAI comprised survival at discharge and Glasgow Outcome scale (GOS) after 3 months and also 2 years.
Results: S100BB concentration was maximum in 6 hours after injury (median = 280.75 ng/L) followed by a quick drop. Its value was significantly higher on third day in patients with unfavorable outcome (GOS score = 1-3) versus favorable outcome (GOS score = 4, 5) (p < 0.0001). The values of NSE had mild changes during 3 days; however, these measured values at 72 hours after trauma manifested higher in unfavorable outcome (p < 0.05).
Conclusions: Increased serum concentrations of NSE and S100BB within first 3 days after DAI are associated with poor outcome despite mild CT findings. S100BB level at 72 hours after injury can predict late outcome in DAI patients.
Level of evidence: Prognostic study, level III.
Copyright © 2012 by Lippincott Williams & Wilkins.
Similar articles
-
Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.J Neurosurg. 2016 Sep;125(3):631-41. doi: 10.3171/2015.6.JNS15674. Epub 2016 Jan 1. J Neurosurg. 2016. PMID: 26722854 Clinical Trial.
-
Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography.J Neurotrauma. 2000 Feb;17(2):113-22. doi: 10.1089/neu.2000.17.113. J Neurotrauma. 2000. PMID: 10709869
-
Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial: clinical article.J Neurosurg. 2013 Jun;118(6):1298-303. doi: 10.3171/2013.1.JNS121181. Epub 2013 Mar 1. J Neurosurg. 2013. PMID: 23451906
-
Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis.BMJ. 2013 Apr 4;346:f1757. doi: 10.1136/bmj.f1757. BMJ. 2013. PMID: 23558282 Review.
-
The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis.PLoS One. 2014 Sep 4;9(9):e106680. doi: 10.1371/journal.pone.0106680. eCollection 2014. PLoS One. 2014. PMID: 25188406 Free PMC article. Review.
Cited by
-
What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment.Int J Mol Sci. 2015 May 26;16(6):11903-65. doi: 10.3390/ijms160611903. Int J Mol Sci. 2015. PMID: 26016501 Free PMC article. Review.
-
Single versus Serial Measurements of Neuron-Specific Enolase and Prediction of Poor Neurological Outcome in Persistently Unconscious Patients after Out-Of-Hospital Cardiac Arrest - A TTM-Trial Substudy.PLoS One. 2017 Jan 18;12(1):e0168894. doi: 10.1371/journal.pone.0168894. eCollection 2017. PLoS One. 2017. PMID: 28099439 Free PMC article. Clinical Trial.
-
Post-traumatic Headache and Mild Traumatic Brain Injury: Brain Networks and Connectivity.Curr Pain Headache Rep. 2021 Mar 5;25(3):20. doi: 10.1007/s11916-020-00935-y. Curr Pain Headache Rep. 2021. PMID: 33674899 Review.
-
Neurological Damage Measured by S-100b and Neuron-Specific Enolase in Patients Treated with Electroconvulsive Therapy.Brain Sci. 2024 Aug 16;14(8):822. doi: 10.3390/brainsci14080822. Brain Sci. 2024. PMID: 39199513 Free PMC article.
-
Blood Biomarkers in Moderate-To-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome.Front Neurol. 2015 May 26;6:110. doi: 10.3389/fneur.2015.00110. eCollection 2015. Front Neurol. 2015. PMID: 26074866 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous